N-Acetylation and hydroxylation polymorphisms in type II diabetics with microvascular disturbances B. Gawrońska-SzklarzW. GórnikZ. Sych PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 431 - 435
Aetiology and therapy of community-acquired pneumonia: a hospital study in northern Italy L. GuglielmoR. Leonemembers of the Veneto Pneumonia Research Group PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 437 - 443
An algorithm for the design of epidemiologic studies applied to drug surveillance A. FigueirasF. TatoJ. J. Gestal-Otero PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 445 - 448
Actual use of inhaled corticosteroids and risk of hospitalisation: a case-control study E. Van GanseI. HubloueE. Van Ganse PHARMACOEPIDEMIOLOGY AND PRESCRIPTION Pages: 449 - 454
Relationship between erythrocyte-to-plasma distribution ratio of cyclosporin and lymphocyte proliferation in renal transplant patients N. ShibataN. HoshinoA. Yamaji PHARMACODYNAMICS Pages: 455 - 459
A dose-response study of phenylephrine in critically ill, septic surgical patients L. FlancbaumM. DickP. Choban PHARMACODYNAMICS Pages: 461 - 465
Efficacy of an ultrashort-acting β-adrenoceptor blocker (ONO-1101) in attenuating cardiovascular responses to endotracheal intubation A. KitamuraA. SakamotoR. Ogawa PHARMACODYNAMICS Pages: 467 - 471
Pharmacokinetic-pharmacodynamic modelling as a tool to evaluate the clinical relevance of a drug-food interaction for a nisoldipine controlled-release dosage form H. G. SchaeferR. HeinigJ. Kuhlmann PHARMACODYNAMICS Pages: 473 - 480
Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child B. RambeckG. KurlemannU. Jürgens PHARMACOKINETICS AND DISPOSITION Pages: 481 - 484
Differences between blacks and whites in plasma protein binding of drugs J. A. JohnsonT. N. Livingston PHARMACOKINETICS AND DISPOSITION Pages: 485 - 488
Pharmacokinetics of imidapril and its active metabolite imidaprilat following single dose and during steady state in patients with impaired liver function J. F. W. HoogkamerC. H. KleinbloesemW. Kirch PHARMACOKINETICS AND DISPOSITION Pages: 489 - 491
Pharmacokinetic study and cardiovascular monitoring of nebivolol in normal and obese subjects G. CheymolR. WoestenborghsJ. M. Poirier PHARMACOKINETICS AND DISPOSITION Pages: 493 - 498
Magnesium pyridoxal–5′–phosphate glutamate, “A vitamin B6 derivative”, does not affect lipoprotein levels in patients with familial hypercholesterolaemia H. C. KnipscheerI. KindtJ. J. P. Kastelein PHARMACOKINETICS AND DISPOSITION Pages: 499 - 503
Acute cerebellopathy as a probable toxic effect of flucytosine E. Cubo DelgadoR. Sanz BozaE. Vargas Castrillon CASE REPORT Pages: 505 - 506